Next: All human immunoglobulin V-region
Up: Somatic hypermutation targets the
Previous: Somatic hypermutation targets the
I will use an empirical mutability model, that was
inferred from a database of 520 unselected mutations found in 28511
nucleotides sequenced from JH-CH and
introns
(1996). Cowell et al. (1998) showed that these data are
efficiently described by a mechanism that operates on triplets of
nucleotides, the probability that a nucleotide mutates being
conditioned on the two flanking nucleotides. Cowell and Kepler (in
preparation) inferred from these data the probability of any
nucleotide mutating given its identity and the identity of the two
nucleotides that flank it in the sequence. For each position in the
gene sequence, one can retrieve, from this empirical mutability model,
the predicted mutability under somatic hypermutation. In general I
will be interested in the replacement mutability, defined as the
probability that a nucleotide undergoes a substitution that leads to
an amino acid replacement. Silent substitutions may only contribute to
CDR or FR functional diversity through second order effects, such as
subsequently affecting the mutability of the neighboring nucleotides.
Although the mutability of a nucleotide is essentially a probability,
I will still use the term mutability for historical reasons (see
Kepler (1997)).
The procedure that I designed for calculating an average replacement
mutability per nucleotide in a sequence is the following:
- From the empirical mutability matrix I retrieve the mutability
of the nucleotide, given its identity and the identity of its two
neighboring nucleotides.
- From the empirical transition matrix given in Cowell and Kepler
I retrieve the probability of each of the three possible
substitutions of the nucleotide.
- Each substitution of the original nucleotide by another has a
probability 0 or 1 to lead to an amino acid replacement.
- Then the predicted replacement mutability at a given site is
given by the product of the mutability of the nucleotide
found in the germline sequence at that position, and the sum, over
all three possible substitutions, of the product of the
probability of the specific substitution and the probability that
the given nucleotide substitution leads to an amino acid
replacement.
- I then calculate the predicted average replacement mutability
of a nucleotide in the sequence is calculated by taking the
average over all sites in the sequence of the replacement
mutability per site.
To compare FR and CDR mutabilities, I separately determine the
mutability of FR and CDR sites. I will use the same procedure to
determine the predicted mutability of artificially-constructed
sequences.
Next: All human immunoglobulin V-region
Up: Somatic hypermutation targets the
Previous: Somatic hypermutation targets the
Mihaela Oprea
1999-04-11